Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Yoshiyuki Kusakari"'
Publikováno v:
Case Reports in Dermatology, Vol 7, Iss 3, Pp 322-327 (2015)
Melanoma is an aggressive skin cancer that originates from melanocytes, and about one half of melanoma cases possess a BRAF mutation. Together with PD-L1 expression, the BRAFV600E mutation is one of the optimal therapeutic targets for the treatment o
Externí odkaz:
https://doaj.org/article/d324d1e7dad64f5fa85b08c9d810ba52
Autor:
Kayo Tanita, Taku Fujimura, Aya Kakizaki, Sadanori Furudate, Yoshiyuki Kusakari, Setsuya Aiba
Publikováno v:
Case Reports in Dermatology, Vol 7, Iss 2, Pp 166-170 (2015)
Abatacept is a biological immune modifier that is used for the treatment of rheumatoid arthritis. Although psoriasiform drug eruption is reported as one of the cutaneous adverse effects of abatacept, the precise mechanisms are not fully understood. I
Externí odkaz:
https://doaj.org/article/ba96761c64664c59826746720b476e0c
Autor:
Yusuke Muto, Taku Fujimura, Aya Kakizaki, Kenichiro Tsuchiyama, Yoshiyuki Kusakari, Setsuya Aiba
Publikováno v:
Case Reports in Dermatology, Vol 7, Iss 1, Pp 70-74 (2015)
Lipodystrophy is a group of metabolic disorders, possibly caused by autoimmune disease. In this report, we describe a case of adult-onset acquired partial lipodystrophy accompanied by rheumatoid arthritis without a family history. Interestingly, immu
Externí odkaz:
https://doaj.org/article/4dfcf19ebb3d451abffbadcd1a8e2350
Autor:
Hisayuki Tono, Taku Fujimura, Eimei Iwama, Yoshiyuki Kusakari, Sadanori Furudate, Yumi Kambayashi, Takahiro Haga, Akira Hashimoto, Setsuya Aiba
Publikováno v:
Case Reports in Dermatology, Vol 7, Iss 1, Pp 1-6 (2015)
Merkel cell carcinoma (MCC) is an aggressive, cutaneous, neuroendocrine carcinoma and, in rare cases, occurs with Bowen's disease (BD). In this report, we describe a case of MCC concurrent with invasive BD and compare the profiles of tumor-infiltrati
Externí odkaz:
https://doaj.org/article/edd2d9b0a9a6428a859171e3f1a17a68
Autor:
Mei Nasu-Tababuchi, Taku Fujimura, Aya Kakizaki, Kosuke Shido, Naokazu Hatchome, Yoshiyuki Kusakari, Setsuya Aiba
Publikováno v:
Dermatologica Sinica, Vol 34, Iss 2, Pp 96-98 (2016)
Hypopigmented mycosis fungoides (HMF) is a clinical variant of MF presenting a good prognosis. In this report, we describe a case of HMF with dense infiltration of tumor-infiltrating leukocytes that bear several cytotoxic molecules, such as granulysi
Externí odkaz:
https://doaj.org/article/7c811c0a96ff4c4abb589646c68db813
Autor:
Masayuki Asano, Setsuya Aiba, Akiko Hagiwara-Takita, Kenshi Yamasaki, Toshiya Takahashi, Yoshiyuki Kusakari, Ryoko Shimada-Omori, Kenichiro Tsuchiyama, Mei Nasu-Tamabuchi, Hitoshi Terui, Tomoyuki Ohtani
Publikováno v:
The Journal of dermatologyREFERENCES. 48(11)
Biologics has had a great impact on psoriasis treatment as well as the life of psoriasis patients. Infliximab (IFX), one of the biologics targeting tumor necrosis factor (TNF), is the first of the biologics introduced to Japanese psoriasis patients.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e5e01ce5b53ee0a84a84bd783b2aa0dc
https://pubmed.ncbi.nlm.nih.gov/34355429
https://pubmed.ncbi.nlm.nih.gov/34355429
Autor:
Setsuya Aiba, Takanori Hidaka, Yoji Sasahara, Yoshiko Kagimoto, Kenshi Yamasaki, Reimu Fukui, Yoshiyuki Kusakari, Takeshi Rikiishi, Hitoshi Terui
Publikováno v:
The Journal of dermatologyREFERENCES. 48(7)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1f7afb68ec598ce465bd4faec5b2f3a4
https://pubmed.ncbi.nlm.nih.gov/33960444
https://pubmed.ncbi.nlm.nih.gov/33960444
Autor:
Yoshiyuki Kusakari, Sadanori Furudate, Kayo Tanita, Taku Fujimura, Setsuya Aiba, Aya Kakizaki
Publikováno v:
Case Reports in Dermatology
Case Reports in Dermatology, Vol 7, Iss 2, Pp 166-170 (2015)
Case Reports in Dermatology, Vol 7, Iss 2, Pp 166-170 (2015)
Abatacept is a biological immune modifier that is used for the treatment of rheumatoid arthritis. Although psoriasiform drug eruption is reported as one of the cutaneous adverse effects of abatacept, the precise mechanisms are not fully understood. I
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::376be6261d652099e2b6a8f401805f54
https://doi.org/10.1159/000437415
https://doi.org/10.1159/000437415
Autor:
Setsuya Aiba, Kenichiro Tsuchiyama, Yoshiyuki Kusakari, Ryoko Shimada-Omori, Kenshi Yamasaki, Toshiya Takahashi, Mei Nasu-Tamabuchi
Publikováno v:
The Journal of Dermatology. 42:727-730
The efficacy and safety of biologic treatments have been established in patients with moderate to severe psoriasis, but there are few reports on biologic therapy for patients with psoriasis complicated by end-stage renal failure on hemodialysis (HD).
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4a41a93d1210376f9d3d53d12abab191
https://doi.org/10.1111/1346-8138.12901
https://doi.org/10.1111/1346-8138.12901
Autor:
Setsuya Aiba, Yusuke Muto, Kenichiro Tsuchiyama, Aya Kakizaki, Yoshiyuki Kusakari, Taku Fujimura
Publikováno v:
Case Reports in Dermatology, Vol 7, Iss 1, Pp 70-74 (2015)
Case Reports in Dermatology
Case Reports in Dermatology
Lipodystrophy is a group of metabolic disorders, possibly caused by autoimmune disease. In this report, we describe a case of adult-onset acquired partial lipodystrophy accompanied by rheumatoid arthritis without a family history. Interestingly, immu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::831e529b3473495d739b9252bdfe00ed
http://www.karger.com/Article/FullText/381844
http://www.karger.com/Article/FullText/381844